Stocklytics Platform
Asset logo for symbol AGIO
Agios Pharmaceuticals
AGIO60
$44.87arrow_drop_up1.19%$0.53
Asset logo for symbol AGIO
AGIO60

$44.87

arrow_drop_up1.19%

Performance History

Chart placeholder
Key Stats
Open$44.93
Prev. Close$44.43
EPS-6.43
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range43.98
46.11
52 Week Range19.79
53.29
Ratios
EPS-6.43

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals Inc (AGIO) is a biopharmaceutical company that focuses on developing innovative medicines to treat cancer and rare genetic diseases. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. AGIO is listed on the NASDAQ stock exchange under the ticker symbol AGIO.
AGIO's stock price history has experienced both ups and downs over the years. It is important for investors to analyze the historical performance of the stock before making any investment decisions. AGIO's stock quote provides the current market price of the stock, allowing investors to track its performance on a daily basis.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Brian M. Goff M.B.A.
Headquarters
Cambridge
Employees
389
Exchange
NASDAQ
add Agios Pharmaceuticals  to watchlist

Keep an eye on Agios Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Agios Pharmaceuticals 's (AGIO) price per share?

The current price per share for Agios Pharmaceuticals (AGIO) is $44.87. The stock has seen a price change of $0.53 recently, indicating a 1.19% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Agios Pharmaceuticals (AGIO)?

For Agios Pharmaceuticals (AGIO), the 52-week high is $53.29, which is 18.77% from the current price. The 52-week low is $19.8, the current price is 126.67% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Agios Pharmaceuticals (AGIO) a growth stock?

Agios Pharmaceuticals (AGIO) has shown an average price growth of -3.54% over the past three years. It has received a score of 71 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Agios Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Agios Pharmaceuticals (AGIO) stock price performance year to date (YTD)?

As of the latest data, Agios Pharmaceuticals (AGIO) has a year-to-date price change of 96.54%. Over the past month, the stock has experienced a price change of 0.99%. Over the last three months, the change has been -3.3%. Over the past six months, the figure is 38.06%. Looking at a longer horizon, the five-year price change stands at 49.17%.
help

Is Agios Pharmaceuticals (AGIO) a profitable company?

Agios Pharmaceuticals (AGIO) has a net income of -$352.09M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 64.57% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.23K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $26.82M, with a revenue growth rate of 88.36%, providing insight into the company's sales performance and growth. The gross profit is $17.32M. Operating income is noted at -$391.49M. Furthermore, the EBITDA is -$399.1M.
help

What is the market capitalization of Agios Pharmaceuticals (AGIO)?

Agios Pharmaceuticals (AGIO) has a market capitalization of $2.55B. The average daily trading volume is 44.43, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level